About
Technoclone is a global leader in the development, production, and distribution of diagnostic tests and equipment focused on blood clotting, coagulation, and cardiovascular diseases. Founded in 1987 by Prof. Dr. Bernd R. Binder, the company is known for pioneering the first complete set of ELISAs and a patented system called Actibind, which allows for simultaneous determination of activity and antigen in the same sample. The company specializes in monoclonal antibodies and offers a range of products, including automated and semi-automated coagulation analyzers like the Ceveron® alpha and Ceveron® one, four, and ten. Technoclone also provides comprehensive tests for new oral anticoagulants and OEM products for international diagnostic companies. With a strong emphasis on research and development, Technoclone holds over 10 international patents and collaborates with universities and research consortia worldwide. Its products serve clinical laboratories, academic institutions, and industry partners globally, contributing to advancements in the understanding and management of hematological and cardiovascular disorders.
Technologies
Keywords
Company Information
-
Employees 24
-
Founded 1987
-
Annual Revenue $7500000
Location
67 Brunner Strasse, Vienna, Vienna, Austria, 1230
